NCT01262651 2018-04-23
Sativex® for Relieving Persistent Pain in Participants With Advanced Cancer
GWPharm
Phase 3 Completed
Clinical Trials
4 trialsNCT01975688 2016-08-11
A Pharmacokinetic Study of Single Doses of Sativex in Treatment-induced Mucositis
GWPharm
Phase 1 Terminated
NCT02432612 2016-03-02
A Study to Assess the Pharmacokinetic (PK) Properties of Sativex® in Patients With Advanced Cancer
GWPharm
Phase 1 Withdrawn
NCT00530764 2013-06-20
SPRAY
GWPharm
Phase 2 Completed